Cargando…

A Retrospective Cohort Study of Nasopharyngeal Carcinoma Screening and Hepatocellular Carcinoma Screening in Zhongshang City

Background: Nasopharyngeal carcinoma (NPC) and hepatocellular carcinoma (HCC) have remained a major burden of public health in Southern China. The screening for early disease in asymptomatic individuals has potentially been the most promising tool to improve cancer treatment outcomes. The present st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Xia, Ji, Mingfang, Cheng, Weimin, Wu, Biaohua, Lian, Shifeng, Du, Yun, Cao, Sumei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6547985/ https://www.ncbi.nlm.nih.gov/pubmed/31205549 http://dx.doi.org/10.7150/jca.27676

Ejemplares similares

Assessment of the Long-term Diagnostic Performance of a New Serological Screening Scheme in Large-scale Nasopharyngeal Carcinoma Screening
por: Yu, Xia, et al.
Publicado: (2018)

Mass screening for liver cancer: results from a demonstration screening project in Zhongshan City, China
por: Ji, Mingfang, et al.
Publicado: (2018)

Establishment and validation of a two‐step screening scheme for improved performance of serological screening of nasopharyngeal carcinoma
por: Li, Tingdong, et al.
Publicado: (2018)

Pre-diagnostic anti-EBV antibodies and primary liver cancer risk: a population-based nested case-control study in southern China
por: Du, Yun, et al.
Publicado: (2023)

Efficacy of Chemiluminescence Immunoassays on VCA-IgA and EBNA1-IgA Antibodies of Epstein-Barr Virus in Diagnosing Nasopharyngeal Carcinoma
por: Yu, Xia, et al.
Publicado: (2020)

A polygenic risk score for nasopharyngeal carcinoma shows potential for risk stratification and personalized screening
por: He, Yong-Qiao, et al.
Publicado: (2022)

Screening for Hepatocellular Carcinoma
por: Lui, Hock-Foong
Publicado: (2011)

EBV antibody and gastric cancer risk: a population-based nested case-control study in southern China
por: Du, Yun, et al.
Publicado: (2023)

Nasopharyngeal Epstein-Barr Virus Load: An Efficient Supplementary Method for Population-Based Nasopharyngeal Carcinoma Screening
por: Chen, Yufeng, et al.
Publicado: (2015)

A comprehensive risk score for effective risk stratification and screening of nasopharyngeal carcinoma
por: Zhou, Xiang, et al.
Publicado: (2021)

Detection of Stage I nasopharyngeal carcinoma by Serologic screening and clinical examination
por: Ji, Ming-Fang, et al.
Publicado: (2011)

Screening for hepatocellular carcinoma: What is missing?
por: Mehta, Neil J., et al.
Publicado: (2016)

Screening and bioinformatical analysis of differentially expressed genes in nasopharyngeal carcinoma
por: Guo, Weiqian, et al.
Publicado: (2021)

Screening and identification of key biomarkers in nasopharyngeal carcinoma: Evidence from bioinformatic analysis
por: Zhang, Ji-Zhou, et al.
Publicado: (2019)

Long-Term Survival After Nasopharyngeal Carcinoma Treatment in a Local Prefecture-Level Hospital in Southern China
por: Du, Yun, et al.
Publicado: (2020)

MicroRNAs as Therapeutic Targets in Nasopharyngeal Carcinoma
por: Wang, Sumei, et al.
Publicado: (2019)

Genome-scale CRISPR-Cas9 knockout screening in nasopharyngeal carcinoma for radiosensitive and radioresistant genes
por: Zhou, Ziyan, et al.
Publicado: (2023)

A practical method to screen and identify functioning biomarkers in nasopharyngeal carcinoma
por: Liu, Chengyou, et al.
Publicado: (2021)

Screening therapeutic targets of ribavirin in hepatocellular carcinoma
por: Xu, Chen, et al.
Publicado: (2018)

Screening for hepatocellular carcinoma: patient selection and perspectives
por: Fateen, Waleed, et al.
Publicado: (2017)

Screening for Hepatocellular Carcinoma in Patients with Hepatitis B
por: Sachar, Yashasavi, et al.
Publicado: (2021)

Evaluation of screening for nasopharyngeal carcinoma: trial design using Markov chain models
por: Chen, H H, et al.
Publicado: (1999)

Screening Key Genes and Biological Pathways in Nasopharyngeal Carcinoma by Integrated Bioinformatics Analysis
por: Tai, Junhu, et al.
Publicado: (2022)

The human oral – nasopharynx microbiome as a risk screening tool for nasopharyngeal carcinoma
por: Hao, Yu, et al.
Publicado: (2022)

Application of narrow band imaging and Lugol's iodine staining in screening for nasopharyngeal carcinoma
por: Yang, Fan, et al.
Publicado: (2023)

Exosomes in Nasopharyngeal Carcinoma
por: Zhou, Yujuan, et al.
Publicado: (2018)

Is Screening or Resection of “Minimal” (Early) Hepatocellular Carcinoma Justified?
por: Lanois, B.
Publicado: (1990)

Early serum screening for hepatocellular-carcinoma in patients with hepatitis
por: Neguț, Alina Cristina, et al.
Publicado: (2014)

Hepatocellular Carcinoma Screening Process Failures in Patients with Cirrhosis
por: Marquardt, Patrick, et al.
Publicado: (2021)

Screening for Hepatocellular Carcinoma in Chronic Hepatitis B: An Update
por: Lok, James, et al.
Publicado: (2021)

Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis
por: Zhou, Zengyuan, et al.
Publicado: (2019)

Multiple “Omics” data-based biomarker screening for hepatocellular carcinoma diagnosis
por: Liu, Xiao-Na, et al.
Publicado: (2019)

Fluctuations of Epstein-Barr Virus Serological Antibodies and Risk for Nasopharyngeal Carcinoma: A Prospective Screening Study with a 20-Year Follow-Up
por: Cao, Su-Mei, et al.
Publicado: (2011)

Molecular Screening of Nasopharyngeal Carcinoma: Detection of LMP-1, LMP-2 Gene Expression in Vietnamese Nasopharyngeal Swab Samples
por: Lao, Thuan Duc, et al.
Publicado: (2019)

Hepatocellular carcinoma: cost-effectiveness of screening. A systematic review
por: Ruggeri, Matteo
Publicado: (2012)

Evaluation of Abdominal Ultrasonography Mass Screening for Hepatocellular Carcinoma in Taiwan
por: Yeh, Yen-Po, et al.
Publicado: (2014)

Perspectives of physicians regarding screening patients at risk of hepatocellular carcinoma
por: Bharadwaj, Shishira, et al.
Publicado: (2016)

The Value of Survivin Gene and Proliferation of Hepatocytes in Screening for Hepatocellular Carcinoma
por: Jia, Ke Dong, et al.
Publicado: (2009)

A Practical Guideline for Hepatocellular Carcinoma Screening in Patients at Risk
por: Frenette, Catherine T., et al.
Publicado: (2019)

Screening Hub Genes of Hepatocellular Carcinoma Based on Public Databases
por: Gao, Shan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_if9t1bsone5p09vi71okdkb7rt